Chronic Total Occlusion is Not a Risk Factor for Mortality in Patients With Successful Percutaneous Coronary

Emil N Holck1,2, Naja S Winther1,2, Lone Juul-Hune Mogensen1,2

  • 1Department of Cardiology Aarhus University Hospital Aarhus Denmark.

Insights

Percutaneous coronary intervention for chronic total occlusion (CTO PCI) shows similar long-term mortality to non-CTO PCI when successful. However, unsuccessful CTO PCI is linked to significantly higher long-term mortality.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Fifteen percent of patients with coronary artery disease (CAD) have chronic total occlusions (CTOs).
  • CTOs pose a challenge in percutaneous coronary intervention (PCI).
  • Long-term outcomes of CTO PCI versus non-CTO PCI require further investigation.

Purpose of the Study:

  • To compare the long-term prognosis of successful and unsuccessful CTO PCI with PCI for non-CTO lesions.
  • To evaluate the impact of CTO revascularization on all-cause mortality.

Main Methods:

  • An observational, region-wide, register-based cohort study.
  • Included patients undergoing PCI in Denmark from 2009 to 2019.
  • Stratified patients into non-CTO, successful CTO PCI, and unsuccessful CTO PCI groups.
  • Primary endpoint: all-cause mortality, followed until January 1, 2022.

Main Results:

  • In 21,141 patients, 2,108 underwent CTO PCI.
  • Long-term all-cause mortality was higher after CTO PCI compared to non-CTO PCI, but not statistically significant after adjustment.
  • Successful CTO PCI showed no difference in mortality compared to non-CTO PCI (adjusted HR, 0.99).
  • Unsuccessful CTO PCI was associated with significantly higher long-term mortality (adjusted HR, 1.35).

Conclusions:

  • Patients undergoing PCI for CTO have higher long-term mortality risk than those without CTO.
  • Successful CTO PCI is associated with comparable long-term mortality to non-CTO PCI.
  • Failed CTO PCI significantly increases long-term mortality, highlighting the need for specialized CTO programs with high success rates.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
7